Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schell

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Nature Communications|October 3, 2025
Persistence and clearance of oral human papillomavirus among a multi-national cohort of menBrittney L Dickey, Racheal S Dube Mandishora, Bradley Sirak, et al.
Oral Oncology|June 24, 2014
Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancerNikhil G Rao, Andy Trotti, Jongphil Kim, et al.
The American Journal of Pathology|June 6, 2009
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancerJian-Ping Guo, Shao-Kun Shu, Lili He, et al.
Journal of Surgical Oncology|August 24, 2017
Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancerAaron U Blackham, Syeda M H Naqvi, Michael J Schell, et al.
Oral Oncology|April 24, 2019
Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) casesLaura Martin-Gomez, William J Fulp, Michael J Schell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancerEric B Haura, Tawee Tanvetyanon, Alberto Chiappori, et al.
BMC Cancer|August 13, 2020
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinomaDavid T Pointer, David Roife, Benjamin D Powers, et al.
The American Journal of Clinical Nutrition|October 26, 2002
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal womenLeAnne T Bloedon, A Robert Jeffcoat, Wlodek Lopaczynski, et al.
Cancer Medicine|May 27, 2022
Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancerBrittney L Dickey, Belinda Nedjai, Matthew D Preece, et al.
JAMA Oncology|May 1, 2020
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract CancerRichard D Kim, Vincent Chung, Olatunji B Alese, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Nature Communications|October 3, 2025
Persistence and clearance of oral human papillomavirus among a multi-national cohort of menBrittney L Dickey, Racheal S Dube Mandishora, Bradley Sirak, et al.
Oral Oncology|June 24, 2014
Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancerNikhil G Rao, Andy Trotti, Jongphil Kim, et al.
The American Journal of Pathology|June 6, 2009
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancerJian-Ping Guo, Shao-Kun Shu, Lili He, et al.
Journal of Surgical Oncology|August 24, 2017
Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancerAaron U Blackham, Syeda M H Naqvi, Michael J Schell, et al.
Oral Oncology|April 24, 2019
Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) casesLaura Martin-Gomez, William J Fulp, Michael J Schell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancerEric B Haura, Tawee Tanvetyanon, Alberto Chiappori, et al.
BMC Cancer|August 13, 2020
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinomaDavid T Pointer, David Roife, Benjamin D Powers, et al.
The American Journal of Clinical Nutrition|October 26, 2002
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal womenLeAnne T Bloedon, A Robert Jeffcoat, Wlodek Lopaczynski, et al.
Cancer Medicine|May 27, 2022
Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancerBrittney L Dickey, Belinda Nedjai, Matthew D Preece, et al.
JAMA Oncology|May 1, 2020
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract CancerRichard D Kim, Vincent Chung, Olatunji B Alese, et al.
Pageof 16